Advertisement
Canada markets close in 5 hours 9 minutes

  • S&P/TSX

    21,748.26
    -125.46 (-0.57%)
     

  • S&P 500

    5,002.24
    -69.39 (-1.37%)
     

  • DOW

    37,781.72
    -679.20 (-1.77%)
     

  • CAD/USD

    0.7298
    +0.0000 (+0.01%)
     

  • CRUDE OIL

    82.24
    -0.57 (-0.69%)
     

  • Bitcoin CAD

    86,884.88
    -2,439.17 (-2.73%)
     

  • CMC Crypto 200

    1,375.77
    -6.80 (-0.49%)
     

  • GOLD FUTURES

    2,356.30
    +17.90 (+0.77%)
     

  • RUSSELL 2000

    1,967.65
    -27.77 (-1.39%)
     

  • 10-Yr Bond

    4.7120
    +0.0600 (+1.29%)
     

  • NASDAQ

    15,443.94
    -268.81 (-1.71%)
     

  • VOLATILITY

    16.94
    +0.97 (+6.07%)
     

  • FTSE

    8,063.06
    +22.68 (+0.28%)
     

  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     

  • CAD/EUR

    0.6807
    -0.0012 (-0.18%)
     
BREAKING:

HONDA TO SET UP $15B EV PRODUCTION BASE IN CANADA

Automaker to get up to $5B in government assistance for EV battery, assembly plants

Top Ranked Momentum Stocks to Buy for September 12th

Zacks Equity Research

Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, September 12th:

Alexco Resource Corp. (AXU): This environmental consulting services company has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 33.3% over the last 60 days.

Alexco Resource Corp Price and Consensus

Alexco Resource Corp Price and Consensus
Alexco Resource Corp Price and Consensus

Alexco Resource Corp price-consensus-chart | Alexco Resource Corp Quote

Alexco Resource’s shares gained 29% over the last one month more than S&P 500’s rise of 4.1%. The company possesses a Momentum Score of A.

Alexco Resource Corp Price

Alexco Resource Corp Price
Alexco Resource Corp Price

Alexco Resource Corp price | Alexco Resource Corp Quote

ADVERTISEMENT

Option Care Health, Inc. (BIOS): This independent home and alternate site infusion services provider has a Zacks Rank #2 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 21.7% over the last 60 days.

Option Care Health, Inc. Price and Consensus

Option Care Health, Inc. Price and Consensus
Option Care Health, Inc. Price and Consensus

Option Care Health, Inc. price-consensus-chart | Option Care Health, Inc. Quote

Option Care Health’s shares gained 8.2% over the last one month. The company possesses a Momentum Score of A.

Option Care Health, Inc. Price

Option Care Health, Inc. Price
Option Care Health, Inc. Price

Option Care Health, Inc. price | Option Care Health, Inc. Quote

Tech Data Corporation (TECD): This IT distribution and solutions company has a Zacks Rank #2 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 4% over the last 60 days.

Tech Data Corporation Price and Consensus

Tech Data Corporation Price and Consensus
Tech Data Corporation Price and Consensus

Tech Data Corporation price-consensus-chart | Tech Data Corporation Quote

Tech Data’s shares gained 21.2% over the last one month. The company possesses a Momentum Score of B.

Tech Data Corporation Price

Tech Data Corporation Price
Tech Data Corporation Price

Tech Data Corporation price | Tech Data Corporation Quote

Photronics, Inc. (PLAB): This semiconductor photomask manufacturer has a Zacks Rank #2 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 7.1% over the last 60 days.

Photronics, Inc. Price and Consensus

Photronics, Inc. Price and Consensus
Photronics, Inc. Price and Consensus

Photronics, Inc. price-consensus-chart | Photronics, Inc. Quote

Photronics’ shares gained 25% over the last one month. The company possesses a Momentum Score of B.

Photronics, Inc. Price

Photronics, Inc. Price
Photronics, Inc. Price

Photronics, Inc. price | Photronics, Inc. Quote

See the full list of top ranked stocks here

Learn more about the Momentum score and how it is calculated here.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Tech Data Corporation (TECD) : Free Stock Analysis Report
 
Photronics, Inc. (PLAB) : Free Stock Analysis Report
 
Option Care Health, Inc. (BIOS) : Free Stock Analysis Report
 
Alexco Resource Corp (AXU) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.